/

DARE

Dare Bioscience, Inc.Closed

0.7477−0.02 −2.86%USD

NasdaqCM · as of Oct 13, 16:00 ET · 15m delayAfter hours 0.7500 +0.31%

Open

0.7860

Prev close

0.7697

Day range

0.73000.7860

52-week range

0.69003.78

Volume

115.87K0.22×

Mkt cap

14.71M

P/E ttm

—

Fwd P/E

-1.80

EPS ttm

-0.7100

Div yield

0.00%

Earnings

Aug 13, 2026

From 52w high

−80.22%

Price Chart

Yahoo Finance · delayed

DAREOct 13, 2026O 0.7860H 0.7860L 0.7300C 0.7480−0.0020 (−0.27%)Vol 116.10K

SMA 500.8741
SMA 2001.6651

1Y change −64.72% since Oct 13, 2025 close539 bars loadedTimes in America/New_YorkDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

DARE Dare Bioscience, Inc. · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: −10.20%
1 month: +5.95%
3 months: −63.86%
6 months: −57.26%
Year to date: −61.24%
1 year: −64.72%

Valuation & ownership

Market cap: 14.71M
Enterprise value: 5.58M
P/E (ttm): —
Forward P/E: -1.80
PEG ratio: —
Price / book: —
Price / sales (ttm): 10.77
EV / EBITDA: -0.62
EPS (ttm): -0.7100
EPS (forward): -0.4150
Beta (5y monthly): 1.01
Dividend yield: 0.00%
Payout ratio: 0.00%
Shares outstanding: 19.67M
Float: 13.50M
Short % of float: 4.71%
Short ratio (days): 3.03
Held by insiders: 12.08%
Held by institutions: 13.37%
Avg volume (3m): 531.53K
50-day average: 0.8847
200-day average: 1.67
52-week change: −64.72%
S&P 500 52-week: +17.03%

Technicals (daily)

RSI (14): 39.4
vs 50-day SMA: −14.42%
vs 200-day SMA: −55.08%
50 / 200-day trend: ▼ 50 below 200
MACD vs signal: ▲ above
ATR (14) % of price: 8.67%
Realised vol (20d, ann.): 66.4%
From 52-week high: −80.21%
From 52-week low: +8.41%

ANR

Analyst Consensus

3 analysts

Consensus

Strong buy

1.33 on a 1 (strong buy) – 5 (sell) scale

Mean target

8.33

+1,014.53% implied

Low 5.00Median 8.00High 12.00

Recommendation trend

Now3 / 0 / 0
1m ago3 / 0 / 0

Buy / hold / sell counts

DES

About Dare Bioscience, Inc.

Yahoo Finance profile

Daré Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide antibacterial gel for the treatment of bacterial vaginosis. It also develops Ovaprene, a hormone-free monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the female genitalia for the treatment of female sexual arousal disorder; DARE-HRT1 to treat vasomotor symptoms in menopausal hormone therapy; DARE-VVA1 for the treatment of dyspareunia or pain during sexual intercourse; and DARE-HPV, a fixed-dose formulation of lopinavir and ritonavir in a soft gel vaginal insert to treat genital human papillomavirus (HPV) infection, cervical intraepithelial neoplasia, and other HPV-related pathologies. In addition, the company develops DARE-PDM1, a hydrogel formulation of diclofenac for vaginal administration to treat primary dysmenorrhea; DARE-204 and DARE-214, injectable formulations of etonogestrel that provides contraception over 6-month and 12-month periods; DARE-FRT1 and DARE-PTB1, an intravaginal ring designed to deliver bio-identical progesterone for luteal phase support as part of an in vitro fertilization treatment plan; and DARE-PTB2 for the prevention of preterm birth. Further, it develops DARE-LARC1, a contraceptive implant delivering levonorgestrel with a woman-centered design controlled contraceptive option; DARE-RH1, an approach to non-hormonal contraception for men and women by targeting the CatSper ion channel; DARE-PTB2 for the prevention and treatment of idiopathic preterm birth through inhibition of a stress response protein; and DARE-GML, which delivers antimicrobial glycerol monolaurate intravaginally. It has a strategic collaboration with MyMenopauseRx. Daré Bioscience, Inc. was founded in 2015 and is headquartered in San Diego, California.

Sector: Healthcare
Industry: Biotechnology
Employees: 21

SEAS

Seasonality · DARE

2014–2026 · monthly returns

Strongest month Jan +16.94%Weakest month Jul −7.57%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	-6.2	-6.1	7.1	25.3	-2.2	-5.4	-42.2	-37.6	12.1	-12.3			−61.3%
2025	4.2	-3.4	-8.0	2.1	0.7	-19.5	0.4	-15.8	4.0	-6.7	-6.1	4.9	−38.1%
2024	5.2	76.6	-14.6	-37.1	33.1	-18.0	-15.1	4.5	-9.5	30.6	-19.0	-8.9	−15.9%
2023	53.0	-18.1	0.0	-3.8	1.0	-9.9	-17.9	-8.4	-32.5	-7.4	-18.2	-11.7	−62.8%
2022	-21.5	-5.1	0.0	-24.2	8.8	0.0	-9.8	-2.7	-7.4	-3.0	-8.2	-6.7	−58.5%
2021	68.7	-17.3	-9.6	-10.7	-15.2	47.7	-18.5	13.6	-4.6	-12.6	23.3	11.1	+49.3%
2020	36.6	-2.7	-22.0	30.6	-5.4	-5.8	12.2	-2.7	-7.5	-3.7	53.8	-9.5	+63.4%
2019	15.0	0.9	69.7	-25.7	-13.5	-5.6	-9.9	4.4	-2.5	4.0	-0.1	1.2	+15.3%
2018	0.3	-41.5	-34.0	50.6	-9.7	2.6	-2.6	-3.5	-11.4	-7.7	-4.2	-17.5	−67.1%
2017	14.4	61.7	-38.0	-31.7	-32.8	19.0	-23.4	-2.1	-6.3	-18.9	-0.8	-13.8	−69.4%
2016	-14.3	-18.8	39.0	21.0	-26.2	-12.4	36.3	-64.7	2.6	-23.9	-15.1	4.6	−74.7%
2015	24.8	6.1	9.5	-33.9	-0.2	-22.7	-12.2	-0.2	-9.2	-0.3	-11.2	-13.6	−55.0%
2014					-17.7	1.6	-30.5	7.7	-2.8	14.9	17.7	8.9	−10.4%

INSD

Insider Activity · DARE

Market-wide insider buying →Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

0 shares

Sells, 6 months

— shares

Net shares

Net change in insider shares

—

Date	Insider	Transaction	Shares	Value
Jun 29, 2026	Rastetter William HDirector	Stock Award(Grant) at price 0.00 per share.	38.9K	—
Jun 29, 2026	Matz Gregory WDirector	Stock Award(Grant) at price 0.00 per share.	30.8K	—
Jun 29, 2026	Steele Robin JoanDirector	Stock Award(Grant) at price 0.00 per share.	26.5K	—
Jun 29, 2026	Kelley Susan LDirector	Stock Award(Grant) at price 0.00 per share.	23.7K	—
Jun 29, 2026	Grossman Jessica DDirector	Stock Award(Grant) at price 0.00 per share.	26.1K	—

DARE

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

DARE

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About Dare Bioscience, Inc.

Seasonality · DARE

Insider Activity · DARE

Congress Trades · DARE

Investors Holding DARE

Investors Holding DARE

Congress Trades · DARE

Insider Activity · DARE

Seasonality · DARE

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About Dare Bioscience, Inc.

Financial Snapshot

Earnings & Dividends

News